Literature DB >> 28710305

Autism spectrum disorder in Say-Barber-Biesecker-Young-Simpson syndrome.

Jessica Merritt1, Joseph C Hart1, Tracy L LeGrow1.   

Abstract

Say-Barber-Biesecker-Young-Simpson syndrome (SBBYSS), also known as Ohdo syndrome SBBYS type, is a rare genetic disorder characterised by dysmorphic facial features and severe intellectual disability, as well as cardiac, dental and hearing abnormalities. There has been little psychiatric or psychological description of children with SBBYSS, although previous reports noted repetitive self-injurious behaviours, sensitivity to light and noise and severe deficits in communication. In this report, a 4-year-old male with SBBYSS is described with a focus on psychiatric and psychological assessment, including formal testing for autism spectrum disorder (ASD). Results of multiple behavioural assessment scales are reported. Testing revealed characteristic ASD features, and the patient met criteria for ASD diagnosis in the context of SBBYSS. His behaviours improved with Applied Behavioural Analysis therapy and communication skills training. This is the first documented case of ASD reported alongside SBBYSS. These results suggest ASD may be a clinical feature of SBBYSS. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  Child and adolescent psychiatry; Child and adolescent psychiatry (paediatrics); Congenital disorders; Genetics; Neuro genetics

Mesh:

Year:  2017        PMID: 28710305      PMCID: PMC5534731          DOI: 10.1136/bcr-2017-219930

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  5 in total

1.  Whole-exome-sequencing identifies mutations in histone acetyltransferase gene KAT6B in individuals with the Say-Barber-Biesecker variant of Ohdo syndrome.

Authors:  Jill Clayton-Smith; James O'Sullivan; Sarah Daly; Sanjeev Bhaskar; Ruth Day; Beverley Anderson; Anne K Voss; Tim Thomas; Leslie G Biesecker; Philip Smith; Alan Fryer; Kate E Chandler; Bronwyn Kerr; May Tassabehji; Sally-Ann Lynch; Malgorzata Krajewska-Walasek; Shane McKee; Janine Smith; Elizabeth Sweeney; Sahar Mansour; Shehla Mohammed; Dian Donnai; Graeme Black
Journal:  Am J Hum Genet       Date:  2011-11-11       Impact factor: 11.025

2.  A clinical and genetic study of the Say/Barber/Biesecker/Young-Simpson type of Ohdo syndrome.

Authors:  R Day; B Beckett; D Donnai; A Fryer; M Heidenblad; P Howard; B Kerr; S Mansour; U Maye; S McKee; S Mohammed; E Sweeney; M Tassabehji; B B A de Vries; J Clayton-Smith
Journal:  Clin Genet       Date:  2008-09-16       Impact factor: 4.438

Review 3.  Autism spectrum disorders: the quest for genetic syndromes.

Authors:  Dimitrios I Zafeiriou; Athina Ververi; Vaios Dafoulis; Efrosini Kalyva; Euthymia Vargiami
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2013-05-03       Impact factor: 3.568

4.  Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology.

Authors:  Christopher J McDougle; Lawrence Scahill; Michael G Aman; James T McCracken; Elaine Tierney; Mark Davies; L Eugene Arnold; David J Posey; Andrès Martin; Jaswinder K Ghuman; Bhavik Shah; Shirley Z Chuang; Naomi B Swiezy; Nilda M Gonzalez; Jill Hollway; Kathleen Koenig; James J McGough; Louise Ritz; Benedetto Vitiello
Journal:  Am J Psychiatry       Date:  2005-06       Impact factor: 18.112

5.  Blepharophimosis-mental retardation (BMR) syndromes: A proposed clinical classification of the so-called Ohdo syndrome, and delineation of two new BMR syndromes, one X-linked and one autosomal recessive.

Authors:  Alain Verloes; Dominique Bremond-Gignac; Bertrand Isidor; Albert David; Clarisse Baumann; Marie-Anne Leroy; René Stevens; Yves Gillerot; Delphine Héron; Bénédicte Héron; Brigitte Benzacken; Didier Lacombe; Han Brunner; Pierre Bitoun
Journal:  Am J Med Genet A       Date:  2006-06-15       Impact factor: 2.802

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.